Skip to main content
Sale!

KLOW 80mg (KPV/GHK-Cu/BPC157/TB500)

Original price was: $120.00.Current price is: $110.00.

KLOW 80mg is a high-purity research compound for in vitro studies.

VialsQuantityDiscount
First Research2 5%
Most Popular3 10%
Max Savings4 - 9 15%
Purchase & earn 110 points!
Category:

Description

KLOW | 80mg

For In Vitro Research Use Only – Not for Human or Veterinary Use

 

Specifications:
  • Unit Size: 80mg
  • Form: Lyophilized Powder
  • Purity: ?98% (HPLC Verified)
Intended Use:

KLOW is strictly for in vitro laboratory research only. Not for human or animal use. Do not use in food, drugs, or diagnostics.

Legal Disclaimer:

This compound has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. For use by qualified research personnel only.

Terms of Sale:

All Onyx Research sales are final. Purchasers affirm they are trained professionals responsible for proper handling and compliance.

There are no reviews yet.

Be the first to review “KLOW 80mg (KPV/GHK-Cu/BPC157/TB500)”

Your email address will not be published. Required fields are marked *

FDA Disclaimer

The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease. All products are for laboratory developmental research USE ONLY. Products are not for human consumption.

Onyx Research is a chemical supplier. Onyx Research is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. Onyx Research is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.

THE PRODUCTS WE OFFER ARE NOT INTENDED FOR HUMAN USE. THEY ARE INTENDED FOR IN-VITRO AND PRE-CLINICAL RESEARCH PURPOSES ONLY. THE CUSTOMER ACKNOWLEDGES THAT THERE ARE RISKS IN THE HANDLING, USE, AND DISTRIBUTION OF THESE PRODUCTS, AND CERTIFIES THAT IT HAS THE PROPER EQUIPMENT, FACILITIES, AND PERSONNEL FOR MANAGING THOSE RISKS; AND THE CUSTOMER KNOWINGLY ACCEPTS THESE RISKS.